Literature DB >> 21939210

In vivo fluorescence imaging of bone-resorbing osteoclasts.

Toshiyuki Kowada1, Junichi Kikuta, Atsuko Kubo, Masaru Ishii, Hiroki Maeda, Shin Mizukami, Kazuya Kikuchi.   

Abstract

Osteoclasts are giant polykaryons responsible for bone resorption. Because an enhancement or loss of osteoclast function leads to bone diseases such as osteoporosis and osteopetrosis, real-time imaging of osteoclast activity in vivo can be of great help for the evaluation of drugs. Herein, pH-activatable chemical probes BAp-M and BAp-E have been developed for the detection of bone-resorbing osteoclasts in vivo. Their acid dissociation constants (pK(a)) were determined as 4.5 and 6.2 by fluorometry in various pH solutions. These pK(a) values should be appropriate to perform selective imaging of bone-resorbing osteoclasts, because synthesized probes cannot fluoresce intrinsically at physiological pH and the pH in the resorption pit is lowered to about 4.5. Furthermore, BAp-M and BAp-E have a bisphosphonate moiety that enabled the probes to localize on bone tissues. The hydroxyapatite (HA) binding assay in vitro was, therefore, performed to confirm the tight binding of the probes to the bone tissues. Our probes showed intense fluorescence at low pH values but no fluorescence signal under physiological pH conditions on HA. Finally, we applied the probes to in vivo imaging of osteoclasts by using intravital two-photon microscopy. As expected, the fluorescence signals of the probes were locally observed between the osteoclasts and bone tissues, that is, in resorption pits. These results indicate that our pH-activatable probes will prove to be a powerful tool for the selective detection of bone-resorbing osteoclasts in vivo, because this is the first instance where in vivo imaging has been conducted in a low-pH region created by bone-resorbing osteoclasts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21939210     DOI: 10.1021/ja2064582

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  18 in total

1.  Dynamic visualization of RANKL and Th17-mediated osteoclast function.

Authors:  Junichi Kikuta; Yoh Wada; Toshiyuki Kowada; Ze Wang; Ge-Hong Sun-Wada; Issei Nishiyama; Shin Mizukami; Nobuhiko Maiya; Hisataka Yasuda; Atsushi Kumanogoh; Kazuya Kikuchi; Ronald N Germain; Masaru Ishii
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

Review 2.  Dynamic live imaging of bone: opening a new era with 'bone histodynametry'.

Authors:  Masaru Ishii; Sayumi Fujimori; Takeshi Kaneko; Junichi Kikuta
Journal:  J Bone Miner Metab       Date:  2013-04-02       Impact factor: 2.626

3.  Real-time intravital imaging of pH variation associated with osteoclast activity.

Authors:  Hiroki Maeda; Toshiyuki Kowada; Junichi Kikuta; Masayuki Furuya; Mai Shirazaki; Shin Mizukami; Masaru Ishii; Kazuya Kikuchi
Journal:  Nat Chem Biol       Date:  2016-06-06       Impact factor: 15.040

Review 4.  In vivo live imaging of bone cells.

Authors:  Hiroki Mizuno; Junichi Kikuta; Masaru Ishii
Journal:  Histochem Cell Biol       Date:  2018-01-23       Impact factor: 4.304

Review 5.  Clinical imaging of vascular disease in chronic kidney disease.

Authors:  Alan A Sag; Adrian Covic; Gerard London; Marc Vervloet; David Goldsmith; Jose Luis Gorriz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2016-02-22       Impact factor: 2.370

Review 6.  Acidic microenvironment and bone pain in cancer-colonized bone.

Authors:  Toshiyuki Yoneda; Masahiro Hiasa; Yuki Nagata; Tatsuo Okui; Fletcher A White
Journal:  Bonekey Rep       Date:  2015-05-06

7.  An Acid-Activatable Fluorescence Probe for Imaging Osteocytic Bone Resorption Activity in Deep Bone Cavities.

Authors:  Ryu Hashimoto; Masafumi Minoshima; Junichi Kikuta; Shinya Yari; Steven D Bull; Masaru Ishii; Kazuya Kikuchi
Journal:  Angew Chem Int Ed Engl       Date:  2020-09-08       Impact factor: 15.336

8.  In Vivo 3D Histomorphometry Quantifies Bone Apposition and Skeletal Progenitor Cell Differentiation.

Authors:  Shu-Chi A Yeh; Katarzyna Wilk; Charles P Lin; Giuseppe Intini
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

9.  Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut Toxicity.

Authors:  Hayley M Sabol; Adam J Ferrari; Manish Adhikari; Tânia Amorim; Kevin McAndrews; Judith Anderson; Michele Vigolo; Rajwinder Lehal; Meloney Cregor; Sharmin Khan; Pedro L Cuevas; Jill A Helms; Noriyoshi Kurihara; Venkat Srinivasan; Frank H Ebetino; Robert K Boeckman; G David Roodman; Teresita Bellido; Jesus Delgado-Calle
Journal:  Cancer Res       Date:  2021-08-04       Impact factor: 12.701

Review 10.  Bisphosphonates for delivering drugs to bone.

Authors:  Shuting Sun; Jianguo Tao; Parish P Sedghizadeh; Philip Cherian; Adam F Junka; Esmat Sodagar; Lianping Xing; Robert K Boeckman; Venkatesan Srinivasan; Zhenqiang Yao; Brendan F Boyce; Brea Lipe; Jeffrey D Neighbors; R Graham G Russell; Charles E McKenna; Frank H Ebetino
Journal:  Br J Pharmacol       Date:  2021-04-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.